Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Brian O' Mahony; Amy L Dunn; Andrew D Leavitt; F Peyvandi; Johnny Mahlangu; E et al

Dear Users, System will be interrupted for the whole day on the 29 January 2025 for the software upgrade, apologies for any inconvenience this might cause. Regards, WIReDSpace Admin

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Files

Journal Article.pdf (875 KB)

Authors

Publisher

WILEY-BLACKWELL

Citation

WOS

URI

https://hdl.handle.net/10539/39497

Collections

Academic Wits Research Outputs (All submissions)

Full item page

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By